Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4007 Pharmacy

Not Yet Opened 06-16 16:00:00 EDT

913.07

-2.35

-0.26%

High920.33	Low903.87	Vol406.49M
Open916.42	D1 Closing915.41	Amplitude1.80%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O11.77B	T/O Rate--	Tradable Shares0.00
P/B5.419466	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4007","market":"US","secType":"PLATE","nameCN":"Pharmacy","latestPrice":913.0677,"timestamp":1781639999999,"preClose":915.4131,"halted":0,"volume":406494639,"delay":0,"changeRate":-0.002562,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-2.345398,"latestTime":"06-16 16:00:00 EDT","open":916.41547,"high":920.32574,"low":903.87103,"amount":11767183572.67579,"amplitude":0.017975,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1781683200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.419466,"peRate":27.413401,"turnoverRate":0.009159,"increases":68,"decrements":116,"flats":5,"marketCap":3546509734635.625,"floatMarketCap":3397838005754.6875},"requestUrl":"/m/hq/s/BK4007","defaultTab":"news","newsList":[{"id":"2644792453","title":"Reddit Stock And 2 High Quality Undervalued Plays Worth Watching","url":"https://stock-news.laohu8.com/highlight/detail?id=2644792453","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644792453?lang=en_us&edition=fundamental","pubTime":"2026-06-17 10:28","pubTimestamp":1781663302,"startTime":"0","endTime":"0","summary":"With inflation, interest rate paths and growth signals pulling markets in different directions, many investors are looking for solid ground. That is where high quality undervalued stocks come in. This screener focuses on companies with healthy cash generation and sturdy balance sheets that the market has priced cautiously. In a world of mixed policy signals, fragile housing data and uneven manufacturing trends, that combination can appeal to investors who want substance behind every dollar...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/4300003-choice1-main-header/1585186588101","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4300003-choice1-main-header/1585186588101"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/media/nyse-rddt/reddit/news/reddit-stock-and-2-high-quality-undervalued-plays-worth-watc","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/media/nyse-rddt/reddit/news/reddit-stock-and-2-high-quality-undervalued-plays-worth-watc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1989772923.USD","LU0868494708.USD","LU0289739343.SGD","LU0122379950.USD","LU2023250504.SGD","LU2106854487.HKD","SG9999001176.USD","LU1934455194.USD","IE00B1BXHZ80.USD","SGXZ57979304.SGD","LU2491049909.HKD","LU1116320901.HKD","LU0965509101.SGD","LU2361045086.USD","LU1983299246.USD","LU0320765489.SGD","LU1699723380.USD","SG9999001176.SGD","LU2125909593.SGD","LU1037948541.HKD","BK4516","LU0266013472.USD","LU0203347892.USD","SG9999002232.USD","LU0106261612.USD","LU2125909247.SGD","SG9999014542.SGD","SG9999014567.USD","LU1934455277.USD","BK4020","IE00BLSP4239.USD","LITX","LU1037948897.HKD","RDYY","LU0234572021.USD","LU0965509283.SGD","IE0009355771.USD","IE00BBT3K403.USD","BK4559","LU1929549753.HKD","BK4077","IE00BN8TJ469.HKD","LU2290526834.HKD","IE00B2B36J28.USD","LU0211331839.USD","SG9999015341.SGD","SG9999001440.SGD","LU0012050646.USD","LU0205193047.USD","LU2433249047.HKD","SG9999014559.SGD","LU1057294990.SGD","LU1430594728.SGD","LU0965509010.AUD","LU1585245621.USD","LU0130517989.USD","LU1934455863.HKD","LU1066051811.HKD","LU1035773651.USD","LU0320765646.SGD","LU1093756168.USD","LU1093756325.SGD","LU2491050154.USD","LU0208291251.USD","LU0942090050.USD","LU2125154935.USD","LU1023059063.AUD","LU2324357040.USD","LU2468319806.SGD","LU1989771016.USD","LU2543165471.USD","LU0868494617.USD","LU2357627491.SGD","BK4533","IE0002141913.USD","LU0058720904.USD","LU1923622614.USD","LU1974910355.USD","LU2023250843.SGD","LU2112291526.USD","SG9999002224.SGD","LU1571399168.USD","LU2360107168.USD","RDDT","LITE","LU0205194284.USD","LU0130102774.USD","BK4550","LU1061106388.HKD","SG9999014575.USD","LU1066051225.USD","LU0980610538.SGD","LU1941712264.USD","LU2461242641.AUD","IE00BJT1NW94.SGD","IE00BLSP4452.SGD","LU0432979614.USD","LU2491050071.SGD","BK4534","LU0289961442.SGD","LU0106261372.USD","LU1291159041.SGD","BK4007","LU0098860793.USD","LU0203345920.USD","IE00BFTCPJ56.SGD","LU0861579265.USD","MRK","RDTL","LU1861220033.SGD","LU1917777945.USD","LU0985320562.USD","LU0648001328.SGD","LU0240877869.USD","LU1069347547.HKD","LU0511384066.AUD","LU2089984988.USD","LU1116320737.USD","BK4547","SG9999015358.SGD","LU0240878834.USD","LU0965508806.USD","LU0006306889.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","IE000M9KFDE8.USD","LU0289739699.SGD","LU1201861249.SGD","BK4585","LU1162221912.USD","LU2125154778.USD","LU1941712348.USD","LU0477156953.USD","LU1989772840.SGD","LU0070302665.USD","IE00BSNM7G36.USD","LU0265550946.USD","LU0265550359.USD","LU1066051498.USD","LU2361044865.SGD","LU0238689110.USD","LU0348723411.USD","SG9999013999.USD","LU1066053197.SGD","LU1861215975.USD","LU2361044949.HKD","BK4588","LU0859254822.USD","LU2360032135.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644996307","title":"Septerna Chief People Officer Samira Shaikhly sells 6,250 shares worth $219,224.38","url":"https://stock-news.laohu8.com/highlight/detail?id=2644996307","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644996307?lang=en_us&edition=fundamental","pubTime":"2026-06-17 08:32","pubTimestamp":1781656348,"startTime":"0","endTime":"0","summary":"Septerna Chief People Officer Samira Shaikhly exercised stock options for 6,250 shares at $11.7 on June 12, 2026.Shaikhly sold 6,250 shares at a weighted average price of $35.08 in the same session.Her direct common stock holdings fell to 793 shares.She reported 23,750 stock options remaining following the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Septerna Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 16, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL5S60sh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Septerna Chief People Officer Samira Shaikhly sells 6,250 shares worth $219,224.38","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149159571","title":"Pharmaceutical Giant Novo Nordisk Hit by Ransomware Attack, 1TB of Data Stolen and $25 Million Ransom Demanded","url":"https://stock-news.laohu8.com/highlight/detail?id=1149159571","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149159571?lang=en_us&edition=fundamental","pubTime":"2026-06-17 08:02","pubTimestamp":1781654527,"startTime":"0","endTime":"0","summary":"A cyber extortion group asserted on Tuesday that it had stolen over 1TB of data from pharmaceutical behemoth Novo Nordisk A/S and is contemplating selling portions of the data after the company...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4588","IE00BKVL7J92.USD","LU1093756325.SGD","BK4532","LU1093756168.USD","LU0154236417.USD","IE00BZ1G4Q59.USD","NVOX","BK4007","NVO","BK4585","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644796804","title":"Dividend Aristocrats: 3 US Giants That Have Raised Payouts for 25+ Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2644796804","media":"The Smart Investor","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644796804?lang=en_us&edition=fundamental","pubTime":"2026-06-17 07:30","pubTimestamp":1781652600,"startTime":"0","endTime":"0","summary":"Consistently raising dividends for decades is no small feat. These three US Dividend Aristocrats have increased payouts through recessions, crises, and market crashes — making them standout names for long-term income investors.","market":"sg","thumbnail":"https://thesmartinvestor.com.sg/wp-content/uploads/2023/08/Walmart-300x200.png","type":0,"news_type":0,"thumbnails":["https://thesmartinvestor.com.sg/wp-content/uploads/2023/08/Walmart-300x200.png"],"rights":{"source":"thesmartinvestor_highlight","url":"https://thesmartinvestor.com.sg/dividend-aristocrats-3-us-giants-that-have-raised-payouts-for-25-years/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thesmartinvestor.com.sg/dividend-aristocrats-3-us-giants-that-have-raised-payouts-for-25-years/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thesmartinvestor_highlight","symbols":["LU0154236417.USD","LU1674673428.USD","LU2471134796.USD","LU0466842654.USD","IE0002270589.USD","LU0868494617.USD","BK4592","LU2097829019.USD","LU1989764664.SGD","LU0545562505.USD","LU2505996509.AUD","SGXZ31699556.SGD","IE0009355771.USD","BK4597","LU0689472784.USD","LU1066051811.HKD","GB00BDT5M118.USD","LU1496350171.SGD","LU2129689514.USD","LU0238689110.USD","LU2381873111.SGD","BK4596","LU2505996681.GBP","LU2264538146.SGD","LU1732800096.USD","LU0943347566.SGD","LU1988902786.USD","LU0889566641.SGD","LU0310799852.SGD","SG9999018865.SGD","LU0314104364.USD","LU1633808545.USD","LU2750360997.AUD","LU0320765646.SGD","IE00BBT3K403.USD","IE00BKVL7J92.USD","LU0661504455.SGD","LU0950375773.USD","LU0795875086.SGD","LU1674673691.USD","LU1732799900.SGD","IE00B19Z3B42.SGD","IE0000B7K699.USD","LU0061474960.USD","LU0985320562.USD","LU1989772923.USD","LU1914381329.SGD","LU1064131342.USD","BK4534","LU1221951129.SGD","LU2213496289.HKD","LU2129689431.USD","LU1023059063.AUD","LU0097036916.USD","IE00BFTCPJ56.SGD","LU1506573853.SGD","IE00B3T34201.USD","LU0289739699.SGD","LU2028103732.USD","LU2265009873.SGD","LU2430703178.SGD","LU2471134952.CNY","LU2125154778.USD","IE00BDGV0183.EUR","LU0353189763.USD","LU1116320737.USD","LU2403377893.USD","BK4112","LU0265550359.USD","LU1267930813.SGD","LU1894683264.USD","LU1228905540.USD","LU1778281490.HKD","BK4155","LU1629891620.HKD","LU1804176565.USD","LU0210536198.USD","LU0094547139.USD","SG9999001440.SGD","SG9999017495.SGD","BK4007","LU0211328371.USD","LU2461242641.AUD","LU0354030511.USD","LU1003077747.HKD","SG9999002224.SGD","LU0096362180.USD","LU0158827781.USD","LU0345770308.USD","LU1983299246.USD","LU2417539215.USD","LU2506951958.HKD","LU1221951046.USD","SG9999014914.USD","IE000M9KFDE8.USD","IE00B42XCP33.USD","LU0203347892.USD","IE00BJJMRZ35.SGD","BK4581","BK4550","LU2471134879.HKD","LU0795875169.SGD","LU0265550946.USD","LU2360032135.SGD","SG9999001077.SGD","LU1585245621.USD","LU0203345920.USD","BK4533","LU1430594728.SGD","SG9999001176.USD","SG9999014880.SGD","LU1244550221.USD","BK4548","LU1496350502.SGD","LU2023250330.USD","LU1261432733.SGD","IE00BLSP4239.USD","LU2896262040.SGD","LU1066051225.USD","IE00BJT1NW94.SGD","LU1066053197.SGD","LU1061106388.HKD","LU2468319806.SGD","IE000F7OJYX1.SGD","IE00BZ1G4Q59.USD","HK0000819398.USD","LU2764262908.HKD","BK4588","LU0545039389.USD","SG9999013999.USD","SG9999002232.USD","LU1069347547.HKD","LU1989763005.USD","IE00B3PB1722.GBP","IE0034235188.USD","LU0070217475.USD","LU1935042991.SGD","LU0792757196.USD","LU1035773651.USD","LU0175139822.USD","LU1894683348.USD","SG9999001176.SGD","LU0114720955.EUR","LU0689626769.HKD","LU2602419157.SGD","SPGI","LU1363072403.SGD","LU1059921491.USD","LU2506951875.HKD","LU0345774631.USD","IE00B19Z3581.USD","LU1989772840.SGD","LU1929549753.HKD","LU2592432038.USD","LU0820561818.USD","BK4566","LU0098860793.USD","LU0353189680.USD","LU2133065610.SGD","LU1043141123.HKD","LU0640476718.USD","SG9999014906.USD","SGXZ57979304.SGD","LU1066051498.USD","LU0345774391.USD","LU1989764748.USD","LU1116320901.HKD","LU1074936037.SGD","LU1244550577.SGD","LU0820562030.AUD","LU2236285917.USD","LU0053666078.USD","LU0289960550.SGD","IE00BN8TJ469.HKD","LU1032955483.USD","LU2023251221.USD","LU2210149790.SGD","LU2361044865.SGD","LU2506952097.USD","LU1366192091.USD","IE00B2B36J28.USD","LU1196500208.SGD","LU2750360641.GBP","LU0738911758.USD","WMTI","LU1267930490.SGD","LU0122379950.USD","LU1145028129.USD","LU2347655156.SGD","LU0957791311.USD","LU0432979614.USD","IE0034235303.USD","LU0354030438.USD","IE00BSNM7G36.USD","LU0158827948.USD","LU2506952170.USD","LU1032466523.USD","LU1228905037.USD","IE0001KFT4U8.USD","LU0553294199.USD","LU0912757837.SGD","LU0994945656.USD","IE000MB6IJN5.SGD","IE00BFXG1179.USD","LU2756315318.SGD","LU0882574055.USD","IE00BVYPNW00.USD","LU2129689605.HKD","SG9999018857.SGD","LU2471134523.USD","LU2720916845.USD","LU0823417737.USD","LU2764263203.CNY","LU0426412945.USD","LU2756315664.SGD","LU2361045086.USD","LU0210528500.USD","LU0787776722.HKD","LU1815333072.USD","LU2764263039.SGD","IE00B7SZLL34.SGD","IE00BVYPNV92.GBP","LU0256863902.USD","LU1043141396.HKD","LU0345770993.USD","LU1551013425.SGD","LU2271345857.HKD","LU2089984988.USD","LU2111349929.HKD","LU2456880835.USD","LU0417517546.SGD","LU1162221912.USD","LU0823417653.USD","LU2746668974.SGD","LU1989773731.SGD","LU2112291526.USD","LU1551013342.USD","SG9999014898.SGD","LU2095319765.USD","BK4532","LU2125154935.USD","IE000BZT7R73.USD","LU0149725797.USD","LU2487616109.SGD","IE000SO60NU8.SGD","LU1121112475.USD","LU0820561909.HKD","LU0211327993.USD","IE00BLSP4452.SGD","LU2089284900.SGD","IE0002141913.USD","LU1814569148.SGD","LU0345769128.USD","LU0971096721.USD","LU2746668461.USD","LU0345769631.USD","LU2430703095.HKD","BK4568","JNJ","IE000WAW04H5.SGD","LU1244550494.USD","LU1280957306.USD","IE00B19Z9505.USD","LU1057294990.SGD","LU1718418525.SGD","LU2210150020.SGD","BK4585","BK4559","LU2361044949.HKD","LU2430703251.USD","LU0342679015.USD","BK4504","LU0256863811.USD","WMT","LU0234572021.USD","LU0234570918.USD","LU0683600562.USD","IE00B4R5TH58.HKD","LU0949170772.SGD","IE00BGHQF631.EUR","LU2087625088.SGD","IE00B1BXHZ80.USD","LU0124676726.USD","LU0964807845.USD","LU0058720904.USD","LU0426417589.USD","LU2089283258.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644950317","title":"High Tide Inc reports results for the quarter ended April 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2644950317","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644950317?lang=en_us&edition=fundamental","pubTime":"2026-06-17 07:22","pubTimestamp":1781652127,"startTime":"0","endTime":"0","summary":"High Tide Inc reports results for the quarter ended April 30 - Earnings SummaryHigh Tide Inc HITI.V reported quarterly breakeven results per share for the quarter ended April 30, higher than the same ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nL8N42O2EZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HITI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644795579","title":"Silence Therapeutics Shareholders Approve All AGM Resolutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2644795579","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644795579?lang=en_us&edition=fundamental","pubTime":"2026-06-17 06:31","pubTimestamp":1781649118,"startTime":"0","endTime":"0","summary":"Silence Therapeutics ( ($SLN) ) has provided an update. On June 16, 2026, Silence Therapeutics plc held its 2026 Annual General Meeting, at which s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/silence-therapeutics-shareholders-approve-all-agm-resolutions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/silence-therapeutics-shareholders-approve-all-agm-resolutions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LENZ","BK4229","BK4007","BK4139","AGM","BK4195"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644979510","title":"How New Atumelnant and PALSONIFY Data At Crinetics Pharmaceuticals (CRNX) Has Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2644979510","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644979510?lang=en_us&edition=fundamental","pubTime":"2026-06-17 06:28","pubTimestamp":1781648883,"startTime":"0","endTime":"0","summary":"In mid-June 2026, Crinetics Pharmaceuticals reported new clinical data at ENDO 2026 showing that oral atumelnant improved key biomarkers in congenital adrenal hyperplasia and ACTH-dependent Cushing’s syndrome, while PALSONIFY (paltusotine) maintained biochemical control, symptom stability and generally favorable tolerability in acromegaly over periods of up to two years.\nTogether, these results highlight Crinetics’ progress in building an endocrinology franchise that combines an already...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crnx/crinetics-pharmaceuticals/news/how-new-atumelnant-and-palsonify-data-at-crinetics-pharmaceu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crnx/crinetics-pharmaceuticals/news/how-new-atumelnant-and-palsonify-data-at-crinetics-pharmaceu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4528","BK4023","BK4587","ARTY","BK4139","BK4543","CRNX","BK4588","CHAT","AIPO","AIYY","BK4551","BK4007","AI","AGIX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644954807","title":"Wave Life Sciences (WVE) Stock Could Be 73% Undervalued After WVE 006 Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2644954807","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644954807?lang=en_us&edition=fundamental","pubTime":"2026-06-17 06:25","pubTimestamp":1781648747,"startTime":"0","endTime":"0","summary":"Wave Life Sciences (WVE) is back in focus after recent data updates on its RNA editing platform, where lead program WVE-006 for alpha-1 antitrypsin deficiency showed dose-responsive, durable editing and an encouraging safety profile.\nSee our latest analysis for Wave Life Sciences.\nDespite the encouraging WVE-006 data, Wave Life Sciences’ recent share price return has been weak. The stock is at US$6.00 after a 90-day share price decline of 51.85% and a year to date decline of 62.38%, while the...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-wve/wave-life-sciences/news/wave-life-sciences-wve-stock-could-be-73-undervalued-after-w","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-wve/wave-life-sciences/news/wave-life-sciences-wve-stock-could-be-73-undervalued-after-w","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["WVE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644937227","title":"US FDA sends 25 letters to telehealth companies over claims on compounded weight-loss drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2644937227","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644937227?lang=en_us&edition=fundamental","pubTime":"2026-06-17 06:21","pubTimestamp":1781648507,"startTime":"0","endTime":"0","summary":"US FDA sends 25 letters to telehealth companies over claims on compounded weight-loss drugs June 16 (Reuters) - The U.S. Food and Drug Administration issued 25 warning letters to telehealth companies ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nL4N42O23Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0005OL40V9.USD","LLY","LU0061475181.USD","LU1232071149.USD","IE00BKVL7J92.USD","LU2462157665.USD","SG9999015978.USD","LU1291159041.SGD","LU0820562030.AUD","LU0256863902.USD","LU0203202063.USD","LU1061106388.HKD","LU0432979614.USD","LU0316494557.USD","LU0320765059.SGD","LU2237443382.USD","LU2168563687.JPY","IE0002141913.USD","GB00BDT5M118.USD","LLYZ","LU1267930730.SGD","LU2237443622.USD","IE00BJJMRY28.SGD","LU1868836757.USD","LU1623119135.USD","LU1988902786.USD","LU0354030511.USD","LU2417539215.USD","NVOH","LU2089984988.USD","SG9999014880.SGD","BK4599","LU0787776722.HKD","LU0823434740.USD","BK4588","SGXZ57979304.SGD","LU0354030438.USD","SG9999013999.USD","LU2264538146.SGD","BK4007","LU2271345857.HKD","LU2491049909.HKD","LU1804176565.USD","IE00BJT1NW94.SGD","LU1366192091.USD","LU0096364046.USD","LU2237443549.SGD","IE00BKDWB100.SGD","LU0786609619.USD","LU0320765992.SGD","LU0256863811.USD","LU2237443465.HKD","BK4534","SGXZ99366536.SGD","LU2471134796.USD","IE00BK4W5L77.USD","IE00BJJMRX11.SGD","LU0964807845.USD","LU0289739699.SGD","SGXZ51526630.SGD","LU0198837287.USD","LU1323610961.USD","LU2471134952.CNY","LU1974910355.USD","LU0225283273.USD","LU0133085943.USD","LU0823434583.USD","LU0058720904.USD","ELIL","LU2111349929.HKD","ELIS","LU1868837300.USD","LU2089284900.SGD","IE00BZ1G4Q59.USD","LU0154236417.USD","SG9999001176.SGD","LU1551013342.USD","LU2552382215.SGD","LU2896262040.SGD","LU2112291526.USD","BK4581","LU0094547139.USD","IE0004445239.USD","NVO","BK4585","LU1069344957.HKD","LU1057294990.SGD","IE00B1BXHZ80.USD","SG9999001176.USD","IE00BN29S564.USD","LU1064131342.USD","IE00B7KXQ091.USD","LLYX","LU0889565916.HKD","LU2168564149.EUR","LU2168564222.USD","IE00BK4W5M84.HKD","LU0466842654.USD","LU1035775433.USD","IE00BJLML261.HKD","LU1868837136.USD","LU2023250330.USD","LU2265009873.SGD","LU2360106947.USD","IE00BWXC8680.SGD","LU2491050154.USD","LU0114720955.EUR","LU2357305700.SGD","LU2552382058.USD","LU2471134879.HKD","LU0234572021.USD","IE00B1XK9C88.USD","SG9999014906.USD","LU0417517546.SGD","LU2756315318.SGD","LU0640476718.USD","LU0882574139.USD","IE00B775H168.HKD","LU2491050071.SGD","IE0009355771.USD","LU1868836914.USD","IE00BFSS8Q28.SGD","LU2324357040.USD","LU0106261372.USD","LU2746668461.USD","LU0471298777.SGD","LU1712237335.SGD","LU0109394709.USD","LU2361045086.USD","SGXZ81514606.USD","LU2461242641.AUD","LU2750360641.GBP","LU2087625088.SGD","IE00B4JS1V06.HKD","IE0004445015.USD","IE00BFSS7M15.SGD","LU0456855351.SGD","LU1868836591.USD","SG9999018865.SGD","IE00BJJMRZ35.SGD","LU0238689110.USD","LU0708995401.HKD","BK4532","LU0385154629.USD","LU0109391861.USD","BK4516","LU1280957306.USD","LU0683600562.USD","LU0006306889.USD","LU0210536198.USD","LU1551013425.SGD","LU0689472784.USD","LU2552382132.HKD","SG9999015952.SGD","LU0158827948.USD","IE00B2B36J28.USD","LU0079474960.USD","IE00BFTCPJ56.SGD","LU0158827781.USD","LU2237438978.USD","NVOX","LU1145028129.USD","IE0001KFT4U8.USD","IE00BKPKM429.USD","LU0943347566.SGD","LU0097036916.USD","LU1720051108.HKD","LU1983299246.USD","LU0323591593.USD","LU1989771016.USD","LU2108987350.USD","LU2456880835.USD","LU2750360997.AUD","LU2756315664.SGD","LU0882574055.USD","LU1127390331.HKD","LU1548497426.USD","LU1814569148.SGD","LU2236285917.USD","LU2168564065.EUR","LU1917777945.USD","LU2023251221.USD","BK4533","LU1023059063.AUD","LU0203201768.USD","SG9999017495.SGD","SG9999015945.SGD","LLII","LU0471298694.HKD","LU0353189680.USD","LU2063271972.USD","LU2471134523.USD","LU2361044949.HKD","LU2602419157.SGD","LU0672654240.SGD","LU0820561909.HKD","LU2089283258.USD","LU2213496289.HKD","LU0820561818.USD","SG9999014914.USD","LU0122379950.USD","IE00B4R5TH58.HKD","LU2237443978.SGD","LU0353189763.USD","LU1629891620.HKD","LU2468319806.SGD","LU2361044865.SGD","SGXZ31699556.SGD","SG9999014898.SGD","LU2211815571.USD","LU2237443895.HKD","LU1093756325.SGD","LU2028103732.USD","LU1720051017.SGD","LU0823416689.USD","SG9999018857.SGD","SG9999015986.USD","LU2106854487.HKD","LU2168564495.EUR","LU1093756168.USD","LU2746668974.SGD","LU0266013472.USD","LU2023250504.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644934637","title":"Rigel Deal for VEPPANU Cleared, Arvinas Receives Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2644934637","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644934637?lang=en_us&edition=fundamental","pubTime":"2026-06-17 06:00","pubTimestamp":1781647220,"startTime":"0","endTime":"0","summary":"The latest update is out from Arvinas Holding Company ( ($ARVN) ). On May 11, 2026, Arvinas and its subsidiaries, together with Pfizer, signed a li...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rigel-deal-for-veppanu-cleared-arvinas-receives-payment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rigel-deal-for-veppanu-cleared-arvinas-receives-payment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0306806265.USD","LU1894683348.USD","BK4592","LU0225284248.USD","LU1023059063.AUD","SG9999011175.SGD","SGXZ57979304.SGD","LU0058720904.USD","LU1066051498.USD","BK4585","BK4534","LU0868494617.USD","LU0985481810.HKD","SG9999001176.USD","SG9999002232.USD","BK4581","LU1066053197.SGD","ARVN","LU1057294990.SGD","LU0170899867.USD","IE00BBT3K403.USD","LU0456855351.SGD","BK4588","LU1883839398.USD","BK4139","LU1894683264.USD","SG9999003800.SGD","LU0321505868.SGD","LU0234572021.USD","IE00B3T34201.USD","BK4007","LU0306807586.USD","LU0122379950.USD","LU0289739699.SGD","SG9999002224.SGD","BK4533","LU0321505439.SGD","BK4550","BK4568","IE00B19Z3B42.SGD","LU2596442595.SGD","SG9999001176.SGD","RIGL","IE0002270589.USD","IE00BLSP4239.USD","LU0225771236.USD","SG9999013999.USD","IE000M9KFDE8.USD","IE00B19Z3581.USD","PFE","IE00BLSP4452.SGD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644793452","title":"Travere Therapeutics Announces R&D Leadership Transition Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2644793452","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644793452?lang=en_us&edition=fundamental","pubTime":"2026-06-17 05:43","pubTimestamp":1781646233,"startTime":"0","endTime":"0","summary":"Travere Therapeutics ( ($TVTX) ) just unveiled an announcement. On June 12, 2026, Travere Therapeutics announced that Chief Research Officer Willia...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/travere-therapeutics-announces-rd-leadership-transition-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/travere-therapeutics-announces-rd-leadership-transition-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","BK4007","FFTY","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644793665","title":"Assertio Completes Merger with Zydus, Delists from Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2644793665","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644793665?lang=en_us&edition=fundamental","pubTime":"2026-06-17 05:28","pubTimestamp":1781645334,"startTime":"0","endTime":"0","summary":"Assertio Therapeutics ( ($ASRT) ) has issued an announcement. On June 16, 2026, Assertio completed its previously announced merger with India-based...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/assertio-completes-merger-with-zydus-delists-from-nasdaq?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/assertio-completes-merger-with-zydus-delists-from-nasdaq?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ASRT","MNDmain","NQmain","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644793661","title":"Intensity Therapeutics Stockholders Approve Proposals at Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2644793661","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644793661?lang=en_us&edition=fundamental","pubTime":"2026-06-17 05:27","pubTimestamp":1781645256,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Intensity Therapeutics, Inc. ( ($INTS) ). On June 16, 2026, Intensity Therapeutics, Inc. held its annual meetin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/intensity-therapeutics-stockholders-approve-proposals-at-annual-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/intensity-therapeutics-stockholders-approve-proposals-at-annual-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644798730","title":"Travere Therapeutics Names Inrig Incoming Research Chief, Succeeding Rote","url":"https://stock-news.laohu8.com/highlight/detail?id=2644798730","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644798730?lang=en_us&edition=fundamental","pubTime":"2026-06-17 05:13","pubTimestamp":1781644380,"startTime":"0","endTime":"0","summary":"Travere Therapeutics said Chief Research Officer William Rote plans to retire from the company in February.Chief Medical Officer Julia Inrig will expand her responsibilities to include the company's research organization and be named executive vice president, head of research and development and along with her medical chief role, Travere said.\"Since joining Travere in 2017, Bill has played a pivotal role in transforming our company into a recognized leader in rare disease,\" Chief Executive Eric Dube said.Inrig joined the biopharmaceutical company in 2022 as CMO, overseeing clinical development and operations. She previously served as the global head of the Renal Center of Excellence at Iqvia, leading the design of programs that supported regulatory approvals in kidney disease, the company said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FFTY","BK4007","LENZ","BK4139","BK4539","TVTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644793887","title":"Aurora Acquisition Stockholders Approve Directors and Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2644793887","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644793887?lang=en_us&edition=fundamental","pubTime":"2026-06-17 05:09","pubTimestamp":1781644145,"startTime":"0","endTime":"0","summary":"Aurora Acquisition ( ($BETR) ) just unveiled an update. On June 10, 2026, Better Home & Finance Holding Company held its Annual Meeting of Stockhol...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aurora-acquisition-stockholders-approve-directors-and-auditor?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aurora-acquisition-stockholders-approve-directors-and-auditor?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ACB","MSOS","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644760070","title":"Armata Pharmaceuticals shareholders elect seven directors at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2644760070","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644760070?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:44","pubTimestamp":1781642668,"startTime":"0","endTime":"0","summary":"Armata Pharmaceuticals held its annual shareholder meeting on June 11, 2026.Shareholders selected seven directors to serve one-year terms expiring at the 2027 annual meeting.Investors backed an annual schedule for future advisory votes on executive pay; the board determined those votes will be held each year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Armata Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL77kvZr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INVA","ARMP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644276007","title":"SueWallSt opens probe into Elicio Therapeutics officers, directors after 72.53% stock plunge","url":"https://stock-news.laohu8.com/highlight/detail?id=2644276007","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644276007?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:44","pubTimestamp":1781642662,"startTime":"0","endTime":"0","summary":"SueWallSt opened a securities investigation into Elicio Therapeutics tied to disclosures on its ELI-002 7P pancreatic cancer program.Shares fell 72.53% in one session following release of Phase 2 AMPLIFY-7P results that missed the primary disease-free survival endpoint.The probe focuses on whether prior statements on ELI-002 7P prospects or the AMPLIFY-7P program were materially misleading.The alert cited a June 9 Q1 2026 filing showing zero revenue and a widening net loss driven by higher R&D spending.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL4Pybgy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ELTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644776026","title":"Pulmatrix posts audited 2025 net loss of $5.16 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2644776026","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644776026?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:37","pubTimestamp":1781642256,"startTime":"0","endTime":"0","summary":"Pulmatrix filed audited financial results for fiscal 2025 in a Form 10-K/A amendment to correct an audit report date typo.Net loss USD 5.16 million; revenue none; operating expenses USD 5.17 million, driven by USD 5.13 million general and administrative costs.Cash and cash equivalents USD 4.09 million at Dec. 31, 2025; total assets USD 4.14 million; total liabilities USD 329,000.Merger with Cullgen remained pending, subject to conditions including Nasdaq listing approval and China Securities Regulatory Commission clearance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pulmatrix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDLbCKfHD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Pulmatrix posts audited 2025 net loss of $5.16 million","news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PULM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644760062","title":"Travere Therapeutics announces retirement of Chief Research Officer in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2644760062","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644760062?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:36","pubTimestamp":1781642218,"startTime":"0","endTime":"0","summary":"Travere Therapeutics (TVTX) “announced that William Rote, Ph.D., the Company’s chief research officer, plans to retire from the Company in February...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/travere-therapeutics-announces-retirement-of-chief-research-officer-in-2027-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/travere-therapeutics-announces-retirement-of-chief-research-officer-in-2027-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FFTY","TVTX","BK4007","BK4139","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644760122","title":"BRIEF-Arvinas - Pfizer, And Rigel Receive Hart-Scott-Rodino Clearance For License Agreement On June 11, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2644760122","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644760122?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:33","pubTimestamp":1781642003,"startTime":"0","endTime":"0","summary":"BRIEF-Arvinas - Pfizer, And Rigel Receive Hart-Scott-Rodino Clearance For License Agreement On June 11, 2026 June 16  - Arvinas Inc ARVN.O:ARVINAS - PFIZER, AND RIGEL RECEIVE HART-SCOTT-RODINO CLEARANCE FOR LICENSE AGREEMENT ON JUNE 11, 2026 - SEC FILINGARVINAS - RIGEL PAYS $70 MILLION UPFRONT TO ARVINAS AND PFIZER UNDER LICENSE AGREEMENT - SEC FILINGARVINAS - CO AND PFIZER TO RECEIVE $15 MILLION FROM RIGEL UPON TRANSITION COMPLETION - SEC FILINGARVINAS - CO AND PFIZER ELIGIBLE FOR UP TO $320 MILLION IN MILESTONE PAYMENTS AND TIERED ROYALTIES - SEC FILINGSource text: [ID:n0001628280-26-043559]Further company coverage: ARVN.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nFWN42O0GM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARVN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0211},{"period":"1month","weight":0.0212},{"period":"3month","weight":0.1253},{"period":"6month","weight":0.1243},{"period":"1year","weight":0.2644},{"period":"ytd","weight":0.1069}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4007","nameEN":"BK4007"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pharmacy(BK4007) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pharmacy,BK4007,Pharmacy股票,Pharmacy股票老虎,Pharmacy股票老虎国际,Pharmacy行情,Pharmacy股票行情,Pharmacy股价,Pharmacy股市,Pharmacy股票价格,Pharmacy股票交易,Pharmacy股票购买,Pharmacy股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pharmacy(BK4007) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}